Sensory Neuropathy Clinical Trial
Official title:
Short-term Evaluation of Motor and Sensory Function in Post-COVID-19 Patients
SARS-COV-2 infection reframed medical knowledge in many aspects, yet there is still a lot to be discovered. our aim is to evaluate neurological impact of covid-19; if there is any.
Coronavirus disease 19 (COVID-19) can cause neuropsychiatric, psychological and psychosocial impairments. Literature regarding the sensory and motor affection of COVID-19 is still limited. Public health emergencies as COVID-19 are likely to cause adverse neuropsychiatric impacts. Cognitive impairments after SARS-COV-2 infection were noticed, COVID-19 patients complain of poor concentration, declined memory, and insomnia, as well as anxiety and depression symptoms. in a study; Neurological manifestations described in 36.4% of 214 patients with confirmed COVID-19. However, the symptoms described [dizziness (not further defined), headache, and impaired consciousness] are commonplace in many severe infections and represent disturbances in neurological function rather than a neurological disease per se. Anosmia and ageusia have received much attention, but are ubiquitous in other common upper respiratory tract infections. While a reported increased risk of cerebrovascular disease. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02451722 -
Evaluation of Pressure Distribution of Kyboot Shoes in Comparison to Other Foot Wear
|
N/A | |
| Recruiting |
NCT05483816 -
multiSENSory Stimulation to tArgeT Sensory Loss and chronIc Pain in neurOpathic patieNts
|
N/A | |
| Not yet recruiting |
NCT06183008 -
IVIG in Painful Sensory Neuropathy
|
Phase 4 | |
| Completed |
NCT02555930 -
Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO Study
|
||
| Not yet recruiting |
NCT06078527 -
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
|
N/A |